Clinical trial · Interventional
Clinical Evaluation of a Treatment Planning Software and Oncology Information System for Proton Therapy
UW26028: Clinical Evaluation of a Treatment Planning Software and Oncology Information System for Proton Therapy
NCT07759999CI-TRIAL-00121635recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Researchers are doing this study to better understand how certain treatment planning and clinical workflow software systems support the delivery of standard-of-care proton radiation therapy. The main question it aims to answer is how well the software works in the workflow. Participants will receive proton therapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Proton Therapy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Treatment Planning Software | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Treatment Planning Software
- interventionNames
- Device: Treatment Planning Software
Primary outcomes (1)
- measure
- Proportion of verification image assessments resulting in an adaptive replanning decision
- timeFrame
- From the first verification image assessment through completion of proton therapy, up to 22 weeks
- description
- Proportion of evaluable verification image assessments that result in an order for repeat CT simulation and/or treatment plan reoptimization. Each verification image assessment is classified as resulting or not resulting in an adaptive replanning decision.
Secondary outcomes (4)
- measure
- Concordance of RayAdaptive-predicted inadequate target coverage with repeat CT simulation findings
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 years at the time of consent. * Participant is deemed clinically appropriate for standard-of-care proton therapy by treating radiation oncologist and will not require anesthesia for therapy. * Ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria: * Participant has contraindications to proton therapy (per standard clinical guidelines). * Participant is unable to comply with routine treatment workflow or follow-up. * Participants who will be treated with a radiation plan of 5 fractions or fewer.
References
Publications (0)
Data not yet available
No reference posted for this study.